Page 59 - Contract Development News Today

Investegate announcements from AGC Biologics, AGC Biologics and Evax Partner to Advance Promising Equine Allergy Vaccine Candidate

The CDMO supports clinical stages using its Heidelberg site's microbial-based biologics servicesSeattle, Sept. 07, 2022, a leading global Biopharmaceutical Contract Development and Manufacturing Organization

LISBON, Portugal, Sept. 6, 2022 /PRNewswire/ -- Hovione, the leader in spray drying and particle engineering, announced today that it has expanded its continuous manufacturing offering and services.

Leading up to 2025, AstraZeneca plans to expand its scope through new acquisitions, says Pascal Soriot.

Global Next-Generation Biomanufacturing Market was valued at US$ 19.85 Billion in 2021. It is expected to reach US$ 43.16 Billion by 2030, with a CAGR of 9.3%

Net sales up +10.1% reaching €483.8 million in H1-2022 to be compared with €439.4 million restated net sales in H1-2021, driven by both a positive contribution from API Solutions (+6.5%) and a robust

 Net sales up +10.1% reaching €483.8 million in H1-2022 to be compared with €439.4 million restated net sales in H1-2021, driven by both a positive contribution from API Solutions (+6.5%) and a robust performance in CDMO (+22.2%), fostered by strong momentum in large moleculesCore EBITDA margin at 14.5%, improving 1...

Regulatory News: EUROAPI (Paris:EAPI) posted today its 2022 Condensed Half-Year Consolidated Financial Statements for the six months ended June 30, 2022. This document is available for consultation

/PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing...

/PRNewswire/ -- The "Pharmaceutical Aseptic Transfer Market - A Global and Regional Analysis: Focus on System Transfer, Transfer Type, Usability, End User, and...